Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including semaglutide, are widely used for Type 2 diabetes mellitus (T2DM), obesity and related metabolic conditions. Evidence on potential neuropsychiatric effects remains inconsistent. This systematic review and meta-analysis evaluated depression risk among patien...
These findings support integrating structured, coach guided digital lifestyle programs into routine T2D care, particularly in resource limited, real-world settings such as India.
Chhavi G. Mehra, A. M. Raymond, Banshi Saboo et al.· Frontiers in Endocrinology· 0 citations
This study identified and temporally validated key metabolic and clinical markers associated with prevalent T2D in obese Indians using age- and sex-matched case-control analysis and demonstrated good discrimination in obese Indian individuals.
Anagha Vyawahare, Pramod Tripathi, Nidhi Kadam et al.· Frontiers in Clinical Diabet...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.